Ivan Hyep

Insider Reports History

Location
Boston, MA
Signature
/s/ Lara Meisner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ivan Hyep:

Company Role Class Num Shares Value Price $ Report Date Ownership
Bicara Therapeutics Inc. Chief Financial Officer Common Stock 145,355 $2,662,075 $18.31 22 Dec 2025 Direct
Bicara Therapeutics Inc. Chief Financial Officer Stock Option (Right to Buy) 88,984 22 Dec 2025 Direct

Insider Reports Filed by Ivan Hyep

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCAX Bicara Therapeutics Inc. 22 Dec 2025 3 -$133,625 4 Chief Financial Officer 23 Dec 2025, 16:02
BCAX Bicara Therapeutics Inc. 21 Nov 2025 6 -$271,342 4 Chief Financial Officer 25 Nov 2025, 18:42
BCAX Bicara Therapeutics Inc. 09 Oct 2025 3 -$92,619 4 Chief Financial Officer 10 Oct 2025, 17:22
BCAX Bicara Therapeutics Inc. 06 Oct 2025 9 -$438,045 4 Chief Financial Officer 08 Oct 2025, 17:33
BCAX Bicara Therapeutics Inc. 12 Sep 2024 0 $0 3 Chief Financial Officer 12 Sep 2024, 21:19